ArticleNPJ digital medicine2025
AI-driven smartphone screening for acute COPD exacerbations: enhancing health equity in developing regions.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Artificial Intelligence and Machine Learning for Identifying Social Determinants of Health in Low-Income Populations Within United States Health Systems: A Scoping Review.Health science reports · 2026Article
- Diagnosis of Lung Diseases in the Artificial Intelligence Era.International journal of molecular sciences · 2026Article
- Mobile health for chronic obstructive pulmonary disease: a bibliometric analysis based on integrated databases (2000-2025).Frontiers in medicine · 2026Review
- Prevalence, Associate Factors, and Disease Awareness of Chronic Obstructive Pulmonary Disease: A Large-Scale Cross-Sectional Epidemiological Survey.International journal of chronic obstructive pulmonary disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are critical clinical events that necessitate prompt intervention, yet their detection remains challenging in primary care, especially in resource-limited regions where a lack of awareness leads to delayed diagnoses. To address this issue, we developed an AI-based AECOPD detection system that leverages standard smartphone microphones for auscultation, specifically designed for novice users and analyzing sounds to screen for AECOPD without requiring subjective patient-reported scales. Our system demonstrated robust performance, achieving an area under the curve (AUC) of 0.955 (95% CI: 0.929-0.976). A state-transition health-economic model projected per-capita net savings of 456.9 CNY (95% CI: -88.2 to 1,779.3) with a 90.3% probability of positive returns, supporting cost-effective implementation. This research highlights the potential of AI-driven solutions to enhance COPD management in underserved populations, providing a scalable tool to promote health equity where access to pulmonary specialists is constrained.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.